Excess mortality in patients with schizophrenia spectrum disorders in Malaga (Spain): A cohort study
Open Access
- 4 February 2021
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Psychiatric Sciences
- Vol. 30, e11
Abstract
Aims: There is evidence that patients with schizophrenia spectrum disorders present higher mortality in comparison with the general population. The aim of this study was to analyse the causes of mortality and sociodemographic factors associated with mortality, standardised mortality ratios (SMRs), life expectancy and potential years of life lost (YLL) in patients with schizophrenia spectrum disorders in Spain. Methods: The study included a cohort of patients from the Malaga Schizophrenia Case Register (1418 patients; 907 males; average age 42.31 years) who were followed up for a minimum of 10 years (median = 13.43). The factors associated with mortality were analysed with a survival analysis using Cox's proportional hazards regression model. Results: The main causes of mortality in the cohort were circulatory disease (21.45%), cancer (17.09%) and suicide (13.09%). The SMR of the cohort was more than threefold that of the population of Malaga (3.19). The life expectancy at birth was 67.11 years old, which is more than 13 years shorter than that of the population of Malaga. The YLL was 20.74. The variables associated with a higher risk of mortality were age [adjusted hazard ratio (AHR) = 1.069, p < 0.001], male gender (AHR = 1.751, p < 0.001) and type of area of residence (p = 0.028; deprived urban zone v. non-deprived urban area, AHR = 1.460, p = 0.028). In addition, receiving welfare benefit status in comparison with employed status (AHR = 1.940, p = 0.008) was associated with increased mortality. Conclusions: There is excess mortality in patients with schizophrenia spectrum disorders and also an association with age, gender, socioeconomic inequalities and receiving welfare benefits. Efforts directed towards improved living conditions could have a positive effect on reducing mortality.Keywords
This publication has 46 references indexed in Scilit:
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-AnalysisSchizophrenia Bulletin, 2011
- Physical disease in schizophrenia: a population-based analysis in SpainBMC Public Health, 2010
- Review: Mortality in schizophrenia: a measurable clinical endpointJournal of Psychopharmacology, 2010
- Cancer mortality in patients with schizophreniaCancer, 2009
- The Malaga Schizophrenia Case-Register (Resma): Overview of Methodology and Patient CohortInternational Journal of Social Psychiatry, 2009
- Reducing bias through directed acyclic graphsBMC Medical Research Methodology, 2008
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and MortalityEpidemiologic Reviews, 2008
- A Systematic Review of Mortality in SchizophreniaArchives of General Psychiatry, 2007
- Socioeconomic Position and Major Mental DisordersEpidemiologic Reviews, 2004
- Life Table and Mortality Analysis.1979